AIM Statement: AIM Alarmed by Loss of Measles Elimination Status: Urges Congress to Invest Additional $418 Million
This AIM statement responds to the PAHO announcement that the U.S. has lost its measles elimination status.
This AIM statement responds to the PAHO announcement that the U.S. has lost its measles elimination status.
AIM submitted testimony to the House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies.
AIM submitted public comment in March 2026 to the Advisory Committee on Immunization Practices (ACIP).
AIM has issued a statement expressing concern over CDC's changes in childhood immunization recommendations.
AIM has issued a statement expressing concern over ACIP's hepatitis B vaccine recommendations.
AIM submitted public comment in November to the Advisory Committee on Immunization Practices (ACIP).
Vaccines have saved millions of lives and kept millions of families from the devastation of losing a child or loved one to preventable illness.
We support and honor all our CDC colleagues now dealing with the aftermath of this horrific event.
AIM submits statement in support of maintaining a stringent, science-based process for ACIP.
AIM submitted public comment for the May 22, 2025, meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC).